In patients with congenital adrenal hyperplasia, testicular adrenal hyperplasia and tumors can develop.
INTRODUCTION
Testicular adrenal rest tumors (TART) are frequently found in adult males with congenital adrenal hyperplasia 1 . However TART is a rare complication of congenital adrenal hyperplasia (CAH) in childhood. The presence of TART in children is described mostly in case reports The prevalence of TART and their influence on gonad function is described in a study in a larger population of children 5 . The presence of testicular adrenal tumors in male patients with CAH due to 21-hydroxylase deficiency was already described in 1940 by Wilkens et 6 . The occurrence of testicular adrenal rest tumors, although unusual, has been well described in patients with CAH due to 21-hydroxylase deficiency. However, it is described in a rare case report in the literature of TART in patients with the 11-hydroxylase type of CAH. A case of CAH due to 11-hydroxylase deficiency with TART treated by high dose steroid is presented.
PATIENT REPORT
A 3-year-old boy was admitted with complaints of enlarged penis and development of pubic hair. His height-age was 6 years and boneage was 8 years. In physical examination vital signs were stable, pubic hair stage 2, penile length was 9cm (>90%), testis volume was bilateral 2 ml. In laboratory examinations, we detected that plasma ACTH, deoxycorticosterone and testosterone level were high, plasma cortisol level was low, 17-OH progesterone level was normal, plasma renin activation and aldosterone level were low, serum sodium was normal, potassium was low. In view of these findings he was diagnosed with llß-hydroxylase deficient congenital adrenal hyperplasia and hydrocortisone treatment was started at a dose of 20 mg/m 2 /day. The patient underwent physical examination at the age of 5 years; he had not come for follow-up and had not received medication for 2 years. Bilateral testis volume was 5ml. In LH-RH stimulation test LH response was greater than 5 mIU/ml (ICMA). Central precocious puberty was determined and GnRH agonist added to treatment. Hydrocortisone treatment was continued at a dose of 20mg/m 2 /day. For almost five years the patient received GnRH agonist and hydrocortisone treatment but the patient's compliance with treatment was poor. Therefore his metabolic control was poor. At 12-years-old, because of detection of hypertension, patient was referred to a nephrology clinic and angiotensin-converting enzyme inhibitor was added to his treatment. At 13 years old the patient, whose puberty was completed, had a bone-age of 18 years. Although his target height was 170 cm, his final length was 156 cm, much lower than his expected height from the genetic potential. After epiphyses closed dexamethasone treatment was started at a dose of 0.25 mg/day. At 14.9 years-old, on testis ultrasound right testis volume was 42x22x26 mm, left testis volume was 43x24x26 mm, left testis parenchyma was heterogeneous and a hypoechoic mass 10x10 mm in size was detected in the left testis ( Figure 1 ). This hypoechoic mass detected in the left testis was thought to be an adrenal rest tumor in a patient who was diagnosed late and did not cooperate well with treatment. Dexamethasone treatment was given at a dose of 1 mg/day.
A follow-up testis ultrasound was repeated six months later. Tumor size had not changed, so dexamethasone dose was increased to 5 mg/day. Testis ultrasound repeated at the end of the first year revealed that right testis volume was 39x25x43 mm, left testis volume was 32x27x42 mm, there were two hypoechoic nodules 5mm in diameter in the right testis and one hypoechoic nodule 15x5mm in diameter in the left testis. Testis parenchyma was homogeneous. High dose dexamethasone treatment was continued because tumor size had not grown and from heterogeneous testis tissue was converted into homogeneous and tumor size was too small for surgical intervention. Despite high dose steroid treatment, obesity did not develop. Two years later testis ultrasound revealed that right testis volume was 43x24x33 mm, left testis volume was 44x20x33 mm, bilateral testis parenchyma was minimal heterogeneous and there were no hypoechoic nodules in the testes (Figure 2) .
The tumors completely disappeared with 2-year treatment of high dose steroids. Dexamethasone dose was decreased to 0.5 gr/day and we emphasized to him the importance of compliance with treatment. 
DISCUSSION
Given the embryological origin of the adrenal gland in close proximity to the gonad promordium, it is not surprising that ectopic adrenal tissue can be located either along the migratory pathway of the gonads or at the final gonad site. Thus adrenal rest tissue can be found in the celiac plexus and broad ligaments, as well as within the testes and ovaries 7 . Indeed, nodules of ectopic adrenal tissue are commonly noted incidentally by surgeons during inguinal-scrotal operations . Such tissue appears to maintain the biochemical characteristics of ACTH-dependent adrenocortical function 9 . Consequently, in states of ACTH hyper secretion, such as untreated or poorly controlled CAH, ectopic adrenal tissue can became hyperplastic and manifest as testicular tumors. Our patient was diagnosed late, he did not co-operate well with treatment and he came to control irregularly. At follow-up, because of poor cooperation, central precocious puberty was added to his clinical status. We think that in this patient who had poor metabolic control, high ACTH secretion caused testicular adrenal rest tumor development. Testicular adrenal rest tumors are frequently seen in adults and they cause infertility, so diagnosis is important. These tumors are not well defined in children. The reason for this may be that testis ultrasound is not carried out routinely in children. In CAH patients who have poor metabolic control ACTH stimulate adrenal gland continuously and as a result of this rest hyperplasia develops. If the patient is diagnosed at this stage and high dose steroid treatment is started, tumor development may be prevented. Two of our cases, which we followed but we have not yet published, had testicular adrenal rest hyperplasia and were given hydrocortisone at a dosage of 30 mg/m 2 /day for six months and they completely improved. Follow-up testis ultrasound at the third year is still normal. On the other hand in another of our cases testicular adrenal rest tumor size decreased with high dose steroid treatment but did not dissolve completely. For this reason, we performed surgical intervention in this case 10 
.
Experience gained from our patients shows that in childhood, especially at the beginning of puberty in CAH patients, if testis ultrasound is done on routine follow-up, conversion of hyperplasia to tumor may be impeded, because after a tumor is formed improvement is very hard with medical treatment. Testis ultrasound is easy, non invasive and very reliable for detection of adrenal rest hyperplasia and tumor 11 . Small tumors are not palpable and are usually not detected on physical examination. Avila et /.'s study 12 showed that in 12 patients with testicular adrenal rest tissue detected on ultrasound, only two had a clinical detectable testicular mass. Therefore, the absence of palpable tumors does not imply that no testicular adrenal rest tumors are present. In our patient tumor size was 1 cm and clinically nonpalpable. Stikkelbroeck's study demonstrated that in 10 of the 11 patients without palpable abnormalities, ultrasonography revealed tumors ranging in diameter from 0, 2-1, 6 cm in testis 1 . Testicular adrenal rest tumors are usually reported in 21ß-hydroxylase deficient patients since it was first defined 5 . Testicular adrenal rest tumors are reported more rarely in llß-hydroxylase deficient patients 13 . Our patient is llß-hydroxylase deficient CAH and TART was detected at 15-years old. More than 90% of CAH cases are caused by 21-hydroxylase deficiency and llß-hydroxylase deficient CAH is very rare. So TART is reported more rarely in llß-hydroxylase deficient CAH cases than 21ß-hydroxylase deficient CAH. Development of TART is dependent on ACTH stimulation and TART occurs mostly in patients with poor metabolic control. For this reason, all of the enzyme deficiencies which cause CAH can also cause TART. Our patient's metabolic control was very poor; he did not come for check-ups regularly and did not take medication in an orderly manner. On follow-up, plasma ACTH, testosterone level was high. Bone age progressed rapidly, so his final-height is short. Our patient's mid-parenteral height is 170 cm but his final height is 156cm.
In conclusion, during follow-up of CAH in childhood, detection of adrenal tissue in testis is important. Hyperplasia develops in testicular adrenal rest tissue as a result of increased ACTH stimulation in patients with poor metabolic control in childhood, especially in puberty. If hyperplasia is not determined in the early period rest tumors may develop. After the rest tumor develops, response to medical treatment decreases and risk of infertility increases. For this reason monitoring CAH patients with routine testis ultrasound, especially in the peripubertal period, can decrease TART frequency in adult life. In this case we want to point out that TART can be cured through high dose steroid treatment for a long period like two years.
